IMPAC ANNOUNCES NEW VICE PRESIDENT, PROFESSIONAL SERVICES
PRESS RELEASE Mountain View, Calif., October 17, 2005 IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, has named Gerald L. (Gerry) Hogue as Vice President, Professional Services. Mr. Hogue was the founder of OpTx Corporation, formerly IMPAC’s major competitor in the medical oncology arena. He brings significant oncology and pharmaceutical market knowledge and access, and rich functional skills and methodologies in oncology and IT management, systems implementation, process change management and clinical trials to IMPAC/Elekta.
Prior to starting OpTx in 1993, Mr. Hogue was Managing Partner of the Western Canada information technology consulting practice for Price Waterhouse Management Consultants. James Hoey, President and CEO of IMPAC, is pleased to welcome Mr. Hogue to IMPAC/Elekta. “Our clients and prospects have been asking us to provide broad professional services to further enhance our integrated technology product offerings. The wealth of experience and credibility that Gerry brings in this area will allow us to kick-start our strategic services organization and focus immediately on a previously underserved market segment.” Mr. Hogue added “I’m very excited to join IMPAC. Its fully integrated oncology management solutions are second-to-none, and provide clients with the technology platform needed to fully integrate technology with care delivery and business processes to achieve step changes in clinical and operational efficiency and outcomes and position cancer care delivery and research organizations for the future. Our professional services, which will be marketed under the brand name STRATEGIQ™, will allow IMPAC/Elekta to broaden and strengthen its fully integrated IQ™ line of technology products and assist practitioners to realize additional benefits from enabling technologies.” Demonstrations of IMPAC’s IQ line of technology products will be available at IMPAC’s booth # 1122 during the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver, Colorado, October 16-19, 2005. ********